Review



dbs systems capable of current-controlled (ma) stimulation vercise system  (Boston Scientific Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Boston Scientific Corporation dbs systems capable of current-controlled (ma) stimulation vercise system
    After enrollment and baseline evaluation, patients will be <t>bilaterally</t> <t>implanted</t> with <t>DBS</t> electrodes in the VIM and PSA. The electrodes are placed such that one contact is located on the intercommissural line ( ICL ), the neighboring ventral contact in the PSA, and the neighboring dorsal contact in the VIM. After implantation, the neutral contact on the ICL is activated until 3 months follow-up ( 3MFU ). At 3MFU patients are randomized into a blinded crossover phase for 4 months ( gray box ). Depending on randomization, patients receive stimulation in the sequence PSA-VIM or VIM-PSA. Each phase of the crossover starts with a programming visit ( PV ) and ends with an evaluation visit ( EV ). After the blinded crossover phase, the stimulation contacts can be freely chosen until 12MFU
    Dbs Systems Capable Of Current Controlled (Ma) Stimulation Vercise System, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dbs systems capable of current-controlled (ma) stimulation vercise system/product/Boston Scientific Corporation
    Average 90 stars, based on 1 article reviews
    dbs systems capable of current-controlled (ma) stimulation vercise system - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "Deep brain stimulation of the posterior subthalamic area and the thalamus in patients with essential tremor: study protocol for a randomized controlled pilot trial"

    Article Title: Deep brain stimulation of the posterior subthalamic area and the thalamus in patients with essential tremor: study protocol for a randomized controlled pilot trial

    Journal: Trials

    doi: 10.1186/s13063-016-1599-3

    After enrollment and baseline evaluation, patients will be bilaterally implanted with DBS electrodes in the VIM and PSA. The electrodes are placed such that one contact is located on the intercommissural line ( ICL ), the neighboring ventral contact in the PSA, and the neighboring dorsal contact in the VIM. After implantation, the neutral contact on the ICL is activated until 3 months follow-up ( 3MFU ). At 3MFU patients are randomized into a blinded crossover phase for 4 months ( gray box ). Depending on randomization, patients receive stimulation in the sequence PSA-VIM or VIM-PSA. Each phase of the crossover starts with a programming visit ( PV ) and ends with an evaluation visit ( EV ). After the blinded crossover phase, the stimulation contacts can be freely chosen until 12MFU
    Figure Legend Snippet: After enrollment and baseline evaluation, patients will be bilaterally implanted with DBS electrodes in the VIM and PSA. The electrodes are placed such that one contact is located on the intercommissural line ( ICL ), the neighboring ventral contact in the PSA, and the neighboring dorsal contact in the VIM. After implantation, the neutral contact on the ICL is activated until 3 months follow-up ( 3MFU ). At 3MFU patients are randomized into a blinded crossover phase for 4 months ( gray box ). Depending on randomization, patients receive stimulation in the sequence PSA-VIM or VIM-PSA. Each phase of the crossover starts with a programming visit ( PV ) and ends with an evaluation visit ( EV ). After the blinded crossover phase, the stimulation contacts can be freely chosen until 12MFU

    Techniques Used: Sequencing



    Similar Products

    dbs systems capable of current-controlled (ma) stimulation vercise system  (Boston Scientific Corporation)
    90
    Boston Scientific Corporation dbs systems capable of current-controlled (ma) stimulation vercise system
    After enrollment and baseline evaluation, patients will be <t>bilaterally</t> <t>implanted</t> with <t>DBS</t> electrodes in the VIM and PSA. The electrodes are placed such that one contact is located on the intercommissural line ( ICL ), the neighboring ventral contact in the PSA, and the neighboring dorsal contact in the VIM. After implantation, the neutral contact on the ICL is activated until 3 months follow-up ( 3MFU ). At 3MFU patients are randomized into a blinded crossover phase for 4 months ( gray box ). Depending on randomization, patients receive stimulation in the sequence PSA-VIM or VIM-PSA. Each phase of the crossover starts with a programming visit ( PV ) and ends with an evaluation visit ( EV ). After the blinded crossover phase, the stimulation contacts can be freely chosen until 12MFU
    Dbs Systems Capable Of Current Controlled (Ma) Stimulation Vercise System, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dbs systems capable of current-controlled (ma) stimulation vercise system/product/Boston Scientific Corporation
    Average 90 stars, based on 1 article reviews
    dbs systems capable of current-controlled (ma) stimulation vercise system - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    After enrollment and baseline evaluation, patients will be bilaterally implanted with DBS electrodes in the VIM and PSA. The electrodes are placed such that one contact is located on the intercommissural line ( ICL ), the neighboring ventral contact in the PSA, and the neighboring dorsal contact in the VIM. After implantation, the neutral contact on the ICL is activated until 3 months follow-up ( 3MFU ). At 3MFU patients are randomized into a blinded crossover phase for 4 months ( gray box ). Depending on randomization, patients receive stimulation in the sequence PSA-VIM or VIM-PSA. Each phase of the crossover starts with a programming visit ( PV ) and ends with an evaluation visit ( EV ). After the blinded crossover phase, the stimulation contacts can be freely chosen until 12MFU

    Journal: Trials

    Article Title: Deep brain stimulation of the posterior subthalamic area and the thalamus in patients with essential tremor: study protocol for a randomized controlled pilot trial

    doi: 10.1186/s13063-016-1599-3

    Figure Lengend Snippet: After enrollment and baseline evaluation, patients will be bilaterally implanted with DBS electrodes in the VIM and PSA. The electrodes are placed such that one contact is located on the intercommissural line ( ICL ), the neighboring ventral contact in the PSA, and the neighboring dorsal contact in the VIM. After implantation, the neutral contact on the ICL is activated until 3 months follow-up ( 3MFU ). At 3MFU patients are randomized into a blinded crossover phase for 4 months ( gray box ). Depending on randomization, patients receive stimulation in the sequence PSA-VIM or VIM-PSA. Each phase of the crossover starts with a programming visit ( PV ) and ends with an evaluation visit ( EV ). After the blinded crossover phase, the stimulation contacts can be freely chosen until 12MFU

    Article Snippet: Patients are screened for study participation and implanted with DBS systems capable of current-controlled (mA) stimulation (Activa RC/PC, Medtronic or Vercise System, Boston Scientific) in the VIM and PSA bilaterally within 6 weeks of study enrollment.

    Techniques: Sequencing